Freshfields Bruckhaus Deringer and Clayton Utz are advising Chinese baby food maker Biostime International Holdings Ltd. on a proposed $995 million acquisition of Australian vitamins and health supplements company Swisse Wellness Pty Ltd.
Biostime, which is headquartered in Guangzhou and trades on the Hong Kong stock exchange, is buying 83 percent of Melbourne-based Swisse Wellness through a mix of cash and shares. The deal is expected to close by the end of the month.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
